Verition Fund Management
ETNB

Verition Fund Management’s 89bio ETNB Stock Holding History

Verition Fund Management’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-96,800
Closed -$1.42M – 3629
2025
Q3 		$1.42M Buy
+96,800
New +$987K 0.01% 2258

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Verition Fund Management's ETNB Position: Q4 2025 in Review

Verition Fund Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 112,398 shares — an estimated $1.65M sold.

Verition Fund Management first reported a position in ETNB in Q1 2021 and held it in 5 quarters. The position peaked at $2.53M in Q1 2021. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Verition Fund Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Verition Fund Management sold 112,398 89bio shares in Q4 2025, an estimated $1.65M.
  • Verition Fund Management first reported a position in 89bio in Q1 2021 and held it in 5 quarters.
  • Verition Fund Management's 89bio position peaked at $2.53M in Q1 2021.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Verition Fund Management's 13F filing for Q4 2025, filed 13 Feb 2026.